Sugammadex is the first and so far only drug in a new class of muscle relaxant reversal drugs. Known as a selective relaxant bind- ing agent (SRBA), sugammadex offers a unique mechanism in that it encapsulates the muscle-relaxant molecule, rendering it inac- tive. The complex formed is eliminated. This is a form of chemical antagonism, because no direct receptor action is evident.